LeafNLP Demos
Back to explore

Report #2885852

Received Feb 17, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
CA
Recovered
Unknown
Vaccinated
Feb 10, 2026
Onset
Feb 10, 2026
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
PNC21PNEUMO (CAPVAXIVE)MERCK & CO. INC.UNKZ007870—

Symptoms (3)

No adverse eventProduct distribution issueProduct storage error

Symptom narrative

No adverse effects were reported; Medical Assistant called to report the inadvertent administration of CAPVAXIVE that SANOFI stated was non-viable due to extended shipping duration; This spontaneous report was received from a medical assistant and refers to a 58-year-old female patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 26-Jan-2026, the Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) was shipped on and was not received until 06-Feb-2026. On 10-Feb-2026, the patient was inadvertently vaccinated with a dose of Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) injection 168 mcg/ml (lot #Z007870 with valid expiration date reported as 23-Oct-2026) 0.5 mL (route of administration and vaccination site were not reported) administered for prophylaxis. The vaccine was non-viable due to extended shipping duration. The vaccine was placed in the refrigerator with a "do not use" tag attached to it, while waiting for a return shipping label to be sent, and a nurse missed the tag and accidentally administered it to a patient (product storage error). No adverse effects were reported (no adverse event). No additional adverse event (AE) and no product quality complaint (PQC) was noted.